These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 8330832

  • 21. Neuroleptic malignant syndrome in Mexico.
    Montoya A, Ocampo M, Torres-Ruiz A.
    Can J Clin Pharmacol; 2003; 10(3):111-3. PubMed ID: 14506509
    [Abstract] [Full Text] [Related]

  • 22. Neuroleptic malignant syndrome associated with long-term clozapine treatment: report of a case and results of a clozapine rechallenge.
    Huang TL.
    Chang Gung Med J; 2001 Aug; 24(8):522-5. PubMed ID: 11601195
    [Abstract] [Full Text] [Related]

  • 23. Atypical neuroleptic malignant syndrome associated with clozapine treatment.
    Amore M, Zazzeri N, Berardi D.
    Neuropsychobiology; 1997 Aug; 35(4):197-9. PubMed ID: 9246221
    [Abstract] [Full Text] [Related]

  • 24. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
    Friedman JH.
    Mov Disord; 1994 May; 9(3):321-4. PubMed ID: 7913739
    [Abstract] [Full Text] [Related]

  • 25. [The atypical neuroleptic clozapine (Leponex)--current knowledge and recent clinical aspects].
    Klimke A, Klieser E.
    Fortschr Neurol Psychiatr; 1995 May; 63(5):173-93. PubMed ID: 7782019
    [Abstract] [Full Text] [Related]

  • 26. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
    Lee JW.
    Ann Clin Psychiatry; 2007 May; 19(1):9-16. PubMed ID: 17453656
    [Abstract] [Full Text] [Related]

  • 27. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
    Marelli A, Bodini P, Dizioli P, Chiodelli G, Guarneri M, Boldori L.
    Minerva Med; 1996 May; 87(1-2):45-51. PubMed ID: 8610025
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Suspected neuroleptic malignant syndrome during quetiapine-clozapine cross-titration.
    Stoner SC, Berry A.
    J Pharm Pract; 2010 Feb; 23(1):69-73. PubMed ID: 21507795
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Clinical study of neuroleptic malignant syndrome in demented patients--examination of our case and reported cases].
    Kimura T, Yoshida H.
    No To Shinkei; 1994 Sep; 46(9):859-62. PubMed ID: 7999444
    [Abstract] [Full Text] [Related]

  • 33. Catatonia and neuroleptic malignant syndrome: two sides of a coin?
    Vancaester E, Santens P.
    Acta Neurol Belg; 2007 Jun; 107(2):47-50. PubMed ID: 17710840
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Clozapine-induced neuroleptic malignant syndrome: review and report of new cases.
    Sachdev P, Kruk J, Kneebone M, Kissane D.
    J Clin Psychopharmacol; 1995 Oct; 15(5):365-71. PubMed ID: 8830069
    [Abstract] [Full Text] [Related]

  • 36. [Malignant neuroleptic syndrome in patients with dementia].
    Malling BJ.
    Ugeskr Laeger; 1999 Apr 26; 161(17):2541-2. PubMed ID: 10327877
    [Abstract] [Full Text] [Related]

  • 37. Neuroleptic malignant syndrome secondary to quetiapine.
    Gortney JS, Fagan A, Kissack JC.
    Ann Pharmacother; 2009 Apr 26; 43(4):785-91. PubMed ID: 19299325
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.